Weiner LM - Search Results

1

The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma.

von Mehren M, Arlen P, Gulley J, Rogatko A, Cooper HS, Meropol NJ, Alpaugh RK, Davey M, McLaughlin S, Beard MT, Tsang KY, Schlom J, Weiner LM. von Mehren M, et al. Among authors: weiner lm. Clin Cancer Res. 2001 May;7(5):1181-91. Clin Cancer Res. 2001. PMID: 11350882 Clinical Trial.

2

Antitumor effects of a bispecific antibody targeting CA19-9 antigen and CD16.

Garcia de Palazzo I, Holmes M, Gercel-Taylor C, Weiner LM. Garcia de Palazzo I, et al. Among authors: weiner lm. Cancer Res. 1992 Oct 15;52(20):5713-9. Cancer Res. 1992. PMID: 1394194

3

Antierythrocyte autoantibody formation after therapy with interleukin-2 and gamma-interferon.

Perez R, Padavic K, Krigel R, Weiner L. Perez R, et al. Cancer. 1991 May 15;67(10):2512-7. doi: 10.1002/1097-0142(19910515)67:10<2512::aid-cncr2820671021>3.0.co;2-5. Cancer. 1991. PMID: 1901756

4

Phase I evaluation of combination therapy with interleukin 2 and gamma-interferon.

Weiner LM, Padavic-Shaller K, Kitson J, Watts P, Krigel RL, Litwin S. Weiner LM, et al. Cancer Res. 1991 Aug 1;51(15):3910-8. Cancer Res. 1991. PMID: 1906779 Clinical Trial.

5

Phase I evaluation of an anti-breast carcinoma monoclonal antibody 260F9-recombinant ricin A chain immunoconjugate.

Weiner LM, O'Dwyer J, Kitson J, Comis RL, Frankel AE, Bauer RJ, Konrad MS, Groves ES. Weiner LM, et al. Cancer Res. 1989 Jul 15;49(14):4062-7. Cancer Res. 1989. PMID: 2786751 Clinical Trial.

6

Divergent dose-related effects of gamma-interferon therapy on in vitro antibody-dependent cellular and nonspecific cytotoxicity by human peripheral blood monocytes.

Weiner LM, Steplewski Z, Koprowski H, Litwin S, Comis RL. Weiner LM, et al. Cancer Res. 1988 Feb 15;48(4):1042-6. Cancer Res. 1988. PMID: 3123051

7

Antibody delivery and effector cell activation in a phase II trial of recombinant gamma-interferon and the murine monoclonal antibody CO17-1A in advanced colorectal carcinoma.

Weiner LM, Moldofsky PJ, Gatenby RA, O'Dwyer J, O'Brien J, Litwin S, Comis RL. Weiner LM, et al. Cancer Res. 1988 May 1;48(9):2568-73. Cancer Res. 1988. PMID: 3128400

8

Phase I trial of 2B1, a bispecific monoclonal antibody targeting c-erbB-2 and Fc gamma RIII.

Weiner LM, Clark JI, Davey M, Li WS, Garcia de Palazzo I, Ring DB, Alpaugh RK. Weiner LM, et al. Cancer Res. 1995 Oct 15;55(20):4586-93. Cancer Res. 1995. PMID: 7553634 Clinical Trial.

9

CD16+ monocytes in patients with cancer: spontaneous elevation and pharmacologic induction by recombinant human macrophage colony-stimulating factor.

Saleh MN, Goldman SJ, LoBuglio AF, Beall AC, Sabio H, McCord MC, Minasian L, Alpaugh RK, Weiner LM, Munn DH. Saleh MN, et al. Among authors: weiner lm. Blood. 1995 May 15;85(10):2910-7. Blood. 1995. PMID: 7742551 Free article. Clinical Trial.

10

Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects.

Weiner LM, Li W, Holmes M, Catalano RB, Dovnarsky M, Padavic K, Alpaugh RK. Weiner LM, et al. Cancer Res. 1994 Aug 1;54(15):4084-90. Cancer Res. 1994. PMID: 8033141 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

303 results

Search Page

Filters